ICRA Archives - Page 2 of 3 - Express Pharma

Stability of input costs, specialty product launches to support performance of Indian pharma companies in FY2024: ICRA

Indian API industry to grow at 7-8 per cent CAGR in the medium to long term: ICRA

Union Budget 2023: Industry lauds focus on R&D

Pricing pressures and regulatory overhang affect margins of Indian pharma companies in FY2023: ICRA

Pricing pressures, regulatory scrutiny prevail in US generics pharma industry: ICRA

Domestic pharma industry revenues projected to grow six to eight per cent in FY23: ICRA

Indian pharma industry estimated to grow nine to 11 per cent in 2021-22: ICRA

Impact of COVID-19 2.0 on Indian pharma industry is minimal: ICRA

PLI scheme to help India become Aatmanirbhar in APIs; boost investments in high-value generics: ICRA

2019-nCoV, nitrosamine issues trigger supply chain re-jigs